| Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma NL Berinstein, AJ Grillo-Lopez, CA White, I Bence-Bruckler, D Maloney, ... Annals of Oncology 9 (9), 995-1001, 1998 | 655 | 1998 |
| Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. A Iwasaki, BJ Stiernholm, AK Chan, NL Berinstein, BH Barber Journal of immunology (Baltimore, Md.: 1950) 158 (10), 4591-4601, 1997 | 482 | 1997 |
| Combination chemotherapy and ALVAC-CEA/B7. 1 vaccine in patients with metastatic colorectal cancer HL Kaufman, HJ Lenz, J Marshall, D Singh, C Garett, C Cripps, M Moore, ... Clinical Cancer Research 14 (15), 4843-4849, 2008 | 290 | 2008 |
| The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer L Radvanyi, D Singh-Sandhu, S Gallichan, C Lovitt, A Pedyczak, G Mallo, ... Proceedings of the National Academy of Sciences 102 (31), 11005-11010, 2005 | 259 | 2005 |
| Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review NL Berinstein Journal of Clinical Oncology 20 (8), 2197-2207, 2002 | 230 | 2002 |
| Defining the critical hurdles in cancer immunotherapy BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ... Journal of translational medicine 9, 1-15, 2011 | 187 | 2011 |
| 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine B Guinn, MA DeBenedette, TH Watts, NL Berinstein The Journal of Immunology 162 (8), 5003-5010, 1999 | 167 | 1999 |
| Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma … J Mangel, HA Leitch, JM Connors, R Buckstein, K Imrie, D Spaner, ... Annals of oncology 15 (2), 283-290, 2004 | 128 | 2004 |
| Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B‐cell lymphoma treated in the rituximab era … HR Guirguis, MC Cheung, M Mahrous, E Piliotis, N Berinstein, KR Imrie, ... British journal of haematology 159 (1), 39-49, 2012 | 112 | 2012 |
| Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients NL Berinstein, M Karkada, AM Oza, K Odunsi, JA Villella, JJ Nemunaitis, ... Oncoimmunology 4 (8), e1026529, 2015 | 99 | 2015 |
| Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma C Owen, NL Berinstein, A Christofides, LH Sehn Current Oncology 26 (2), 233-240, 2019 | 98 | 2019 |
| Active idiotypic vaccination versus control immunotherapy for follicular lymphoma R Levy, KN Ganjoo, JP Leonard, JM Vose, IW Flinn, RF Ambinder, ... Journal of clinical oncology 32 (17), 1797, 2014 | 92 | 2014 |
| First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer … NL Berinstein, M Karkada, MA Morse, JJ Nemunaitis, G Chatta, ... Journal of translational medicine 10, 1-12, 2012 | 89 | 2012 |
| Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. NL Berinstein, MD Reis, BY Ngan, CA Sawka, HH Jamal, B Kuzniar Journal of clinical oncology 11 (7), 1344-1352, 1993 | 82 | 1993 |
| Stem cell function and engraftment is not affected by" in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma. R Buckstein, K Imrie, D Spaner, A Potichnyj, JB Robinson, S Nanji, ... Seminars in oncology 26 (5 Suppl 14), 115-122, 1999 | 81 | 1999 |
| Comparison of CMV, RSV, SV40 viral and Vλ1 cellular promoters in B and T lymphoid and non-lymphoid cell lines AA Zarrin, L Malkin, I Fong, KD Luk, A Ghose, NL Berinstein Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1446 (1-2 …, 1999 | 78 | 1999 |
| Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2. N Berinstein, R Levy Journal of immunology (Baltimore, Md.: 1950) 139 (3), 971-976, 1987 | 76 | 1987 |
| Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma LK Hicks, A Woods, R Buckstein, J Mangel, N Pennell, L Zhang, K Imrie, ... Bone marrow transplantation 43 (9), 701-708, 2009 | 75 | 2009 |
| Therapeutic vaccines against melanoma and colorectal cancer J Tartaglia, MC Bonnet, N Berinstein, B Barber, M Klein, P Moingeon Vaccine 19 (17-19), 2571-2575, 2001 | 75 | 2001 |
| Enhancing cancer vaccines with immunomodulators NL Berinstein Vaccine 25, B72-B88, 2007 | 74 | 2007 |
